Thermalin Diabetes

Thermalin Diabetes, LLC has identified a portfolio of novel heat-stable and fast-acting insulin analogs. The company is leveraging breakthroughs with significant IP built on 25 years of research on insulin by Dr. Michael Weiss, Chairman of Biochemistry at Case Western Reserve Medical School (CWRU).

Stage: Preclinical

News: Thermalin Raises $17.5 Million,Thermalin Diabetes, LLC awarded $1.49M NIH Phase II SBIR Grant